- Future Students
- Current Students
- Faculty & Staff
Filters: Author is Petrofsky, Mary [Clear All Filters]
Yamazaki Y, Danelishvili L, Wu M, Hidaka E, Katsuyama T, Stang BV, Petrofsky M, Bildfell RJ, Bermudez LE. 2006. The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells.. Cellular microbiology. 8(5):806-14.
Li Y-jun, Petrofsky M, Bermudez LE. 2002. Mycobacterium tuberculosis uptake by recipient host macrophages is influenced by environmental conditions in the granuloma of the infectious individual and is associated with impaired production of interleukin-12 and tumor necrosis factor alpha.. Infection and immunity. 70(11):6223-30.
Bermudez LE, Kolonoski P, Seitz LE, Petrofsky M, Reynolds R, Wu M, Young LS. 2004. SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.. Antimicrobial agents and chemotherapy. 48(9):3556-8.
Bermudez LE, Petrofsky M, Sommer S, Barletta RG. 2010. Peyer's patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination.. Infection and immunity. 78(8):3570-7.
Bermudez LE, Petrofsky M, Sangari F. 2004. Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype.. Cell biology international. 28(5):411-9.
Bermudez LE, Kolonoski P, Petrofsky M, Wu M, Inderlied CB, Young LS. 2003. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.. The Journal of infectious diseases. 187(12):1977-80.